<DOC>
	<DOCNO>NCT01800643</DOCNO>
	<brief_summary>The purpose prospective study evaluate best dose busulfan patient undergo Haematopoietic Stem Cell Transplantation</brief_summary>
	<brief_title>Evaluation Plasmatic Levels Busulfan Patients Undergoing Hematopoietic Stem Cell Transplantation</brief_title>
	<detailed_description>- Busulfan alkylating antineoplastic agent use commonly condition regimen patient undergo Haematopoietic Stem Cell Transplantation ( HSCT ) . Due fact drug variable metabolism different individual , investigator perform plasmatic dosage chemotherapy start condition regimen ( test dose ) way predict best dose conditioning . Busulfan toxicities depend `` Area Under Curve '' Concentration Steady State ( CSS ) . - The investigator randomize group accord route drug administration : per oral intravenously . Dose test perform condition othe pharmacokinetics ( Pk ) study make first day conditioning . The test dose P.O busulfan 1 mg/Kg/dose 32 mg/m2 I.V busulfan . The target dose busulfan condition depends Pk obtain test dose . In first day regimen , sample analyse new AUC adjust . We control group never perform monitoring ( retrospective group ) - Test Dose oral busulfan perform peripheral blood sample time : 0h ( take busulfan ) , 30 ' , 1h , 1,5h , 2h , 3h , 4h , 5h 6h . In first day conditioning sample collect moment . - Test dose I.V busulfan perform time 0h , 30 ' , 45 ' , 1h , 2h , 3h , 4h , 5h , 6h 8h receive I.V busulfan . If patient receive I.V busulfan conditioning , blood sample collect time 0h , 30 ' , 1h , 2h , 3h , 4h , 5h , 6h , 7h 8h take busulfan . The blood sample centrifuge ( 4ยบ C/ 3200 rpm/10 minute ) analyse . - Patients monitor pharmacokinetic 's drug clinical outcome . The investigator evaluate acute chronic toxicity Stem Cell Transplantation .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Myeloproliferative Disorders</mesh_term>
	<mesh_term>Lymphoproliferative Disorders</mesh_term>
	<mesh_term>Busulfan</mesh_term>
	<criteria>Diagnosis hematologic nonhematologic pathology use part condition regimen busulfan ; Men , woman child regardless age ; Performance Status &gt; 80 ECOG &lt; 2 ; Total bilirubin &lt; 2 mg / dl transaminases &lt; 3 time upper limit normal ; Creatinine &lt; 1.5 mg / dl ; LVEF &gt; 50 % echocardiogram MUGA rest ; Pulmonary function test FEV1 &gt; 70 % ; Consent form sign start specific procedure . Presence infectious process uncontrolled activity ; Presence psychiatric disorder ; Pregnancy ;</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Busulfan</keyword>
	<keyword>plasmatic dosage</keyword>
	<keyword>Stem Cell Transplantation</keyword>
</DOC>